The etiological mechanisms underlying liver disease in the context of CF remain incompletely elucidated, although certain CFTR gene mutations, particularly the F508 del homozygous mutation, are identified as augmenting the risk and severity of manifestation [2]. The gene discussed is CFTR; the disease is liver disorder.